{"entity":{"type":"insider","cik":"0001745960","url":"/insider/0001745960","json_url":"/insider/0001745960.json","name":"Versant Voyageurs I, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":77,"n_filings":18,"first":"2020-02-05","last":"2024-08-30","span_basis":"filed_date"},"name_variants":[{"name":"Versant Voyageurs I, L.P.","source":"filing","n_filings":18,"first_seen":"2020-02-05","last_seen":"2024-08-30"}],"transactions":[{"id":2389239,"accession":"0000950170-24-102354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-102354","line_url":"/filing/0000950170-24-102354#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Voyageurs I, L.P.","owner_display_name":"Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":221600.0,"shares_display":"221,600","price_per_share":6.3202,"price_display":"6.32","price_state":"stated","total_value":1400556.32,"total_display":"1,400,556.32","total_whole":"1,400,556","shares_owned_after":3726341.0,"shares_owned_after_display":"3,726,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-28","filed_date":"2024-08-30","scope":"insider"},{"id":6138834,"accession":"0000899243-22-000946","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-000946","line_url":"/filing/0000899243-22-000946","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VII, L.P.","owner_display_name":"Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":16.0002,"price_display":"16.00","price_state":"stated","total_value":16000200.0,"total_display":"16,000,200.00","total_whole":"16,000,200","shares_owned_after":3623023.0,"shares_owned_after_display":"3,623,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider","n_lines":3},{"id":4306343,"accession":"0000899243-21-034627","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-034627","line_url":"/filing/0000899243-21-034627","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VII, L.P.; Versant Voyageurs I, L.P.","owner_display_name":"Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":850000.0,"shares_display":"850,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":11900000.0,"total_display":"11,900,000.00","total_whole":"11,900,000","shares_owned_after":4223023.0,"shares_owned_after_display":"4,223,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-31","scope":"insider","n_lines":3},{"id":2169844,"accession":"0000899243-20-032389","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-20-032389","line_url":"/filing/0000899243-20-032389","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_display_name":"Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10393.0,"shares_display":"10,393","price_per_share":33.148536495718275,"price_display":"33.15","price_state":"stated","total_value":344512.7398,"total_display":"344,512.74","total_whole":"344,513","shares_owned_after":874299.0,"shares_owned_after_display":"874,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2020-12-01","scope":"insider","n_lines":2},{"id":2858129,"accession":"0000899243-20-031918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031918","line_url":"/filing/0000899243-20-031918","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130017.0,"shares_display":"130,017","price_per_share":33.01,"price_display":"33.01","price_state":"stated","total_value":4291861.17,"total_display":"4,291,861.17","total_whole":"4,291,861","shares_owned_after":4818600.0,"shares_owned_after_display":"4,818,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider","n_lines":2},{"id":2385485,"accession":"0000899243-20-031771","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":536.0,"shares_display":"536","price_per_share":33.0938,"price_display":"33.09","price_state":"stated","total_value":17738.2768,"total_display":"17,738.28","total_whole":"17,738","shares_owned_after":4933454.0,"shares_owned_after_display":"4,933,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-19","scope":"insider","n_lines":2},{"id":2385479,"accession":"0000899243-20-031771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4194.0,"shares_display":"4,194","price_per_share":33.0498,"price_display":"33.05","price_state":"stated","total_value":138610.8612,"total_display":"138,610.86","total_whole":"138,611","shares_owned_after":4933927.0,"shares_owned_after_display":"4,933,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider","n_lines":2},{"id":2288331,"accession":"0000899243-20-031322","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_display_name":"Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":33.0125,"price_display":"33.01","price_state":"stated","total_value":6602.5,"total_display":"6,602.50","total_whole":"6,603","shares_owned_after":4937632.0,"shares_owned_after_display":"4,937,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider","n_lines":2},{"id":2288322,"accession":"0000899243-20-031322","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_display_name":"Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":33.774277777777776,"price_display":"33.77","price_state":"stated","total_value":151984.25,"total_display":"151,984.25","total_whole":"151,984","shares_owned_after":4939311.0,"shares_owned_after_display":"4,939,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider","n_lines":4},{"id":2732972,"accession":"0000899243-20-031061","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_display_name":"Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15598.0,"shares_display":"15,598","price_per_share":34.14809555071163,"price_display":"34.15","price_state":"stated","total_value":532641.9944,"total_display":"532,641.99","total_whole":"532,642","shares_owned_after":4942137.0,"shares_owned_after_display":"4,942,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider","n_lines":6},{"id":2908054,"accession":"0000899243-20-030855","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12617.0,"shares_display":"12,617","price_per_share":34.73230482682096,"price_display":"34.73","price_state":"stated","total_value":438217.49,"total_display":"438,217.49","total_whole":"438,217","shares_owned_after":5646377.0,"shares_owned_after_display":"5,646,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider","n_lines":4},{"id":2908042,"accession":"0000899243-20-030855","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26966.0,"shares_display":"26,966","price_per_share":33.82542107839502,"price_display":"33.83","price_state":"stated","total_value":912136.3048,"total_display":"912,136.30","total_whole":"912,136","shares_owned_after":5657523.0,"shares_owned_after_display":"5,657,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider","n_lines":4},{"id":2553289,"accession":"0000899243-20-030745","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030745","line_url":"/filing/0000899243-20-030745","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6300.0,"shares_display":"6,300","price_per_share":33.0556,"price_display":"33.06","price_state":"stated","total_value":208250.28,"total_display":"208,250.28","total_whole":"208,250","shares_owned_after":5681344.0,"shares_owned_after_display":"5,681,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider","n_lines":2},{"id":2553271,"accession":"0000899243-20-030745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030745","line_url":"/filing/0000899243-20-030745","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":33.1285,"price_display":"33.13","price_state":"stated","total_value":102698.35,"total_display":"102,698.35","total_whole":"102,698","shares_owned_after":5686909.0,"shares_owned_after_display":"5,686,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-06","filed_date":"2020-11-10","scope":"insider","n_lines":2},{"id":3319914,"accession":"0000899243-20-030580","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030580","line_url":"/filing/0000899243-20-030580","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_display_name":"Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8848.0,"shares_display":"8,848","price_per_share":33.1473,"price_display":"33.15","price_state":"stated","total_value":293287.3104,"total_display":"293,287.31","total_whole":"293,287","shares_owned_after":5689647.0,"shares_owned_after_display":"5,689,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-05","filed_date":"2020-11-06","scope":"insider","n_lines":2},{"id":3319904,"accession":"0000899243-20-030580","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030580","line_url":"/filing/0000899243-20-030580","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_display_name":"Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":33.1357,"price_display":"33.14","price_state":"stated","total_value":82839.25,"total_display":"82,839.25","total_whole":"82,839","shares_owned_after":5697463.0,"shares_owned_after_display":"5,697,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider","n_lines":2},{"id":2066757,"accession":"0000899243-20-029546","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-029546","line_url":"/filing/0000899243-20-029546","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":33.0325,"price_display":"33.03","price_state":"stated","total_value":26426.0,"total_display":"26,426.00","total_whole":"26,426","shares_owned_after":5699671.0,"shares_owned_after_display":"5,699,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-27","filed_date":"2020-10-28","scope":"insider","n_lines":2},{"id":2066752,"accession":"0000899243-20-029546","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-029546","line_url":"/filing/0000899243-20-029546","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8103.0,"shares_display":"8,103","price_per_share":33.3046,"price_display":"33.30","price_state":"stated","total_value":269867.1738,"total_display":"269,867.17","total_whole":"269,867","shares_owned_after":5700378.0,"shares_owned_after_display":"5,700,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-26","filed_date":"2020-10-28","scope":"insider","n_lines":2},{"id":2101818,"accession":"0000899243-20-028811","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-028811","line_url":"/filing/0000899243-20-028811","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_display_name":"Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4233.0,"shares_display":"4,233","price_per_share":33.4309,"price_display":"33.43","price_state":"stated","total_value":141512.9997,"total_display":"141,513.00","total_whole":"141,513","shares_owned_after":5707536.0,"shares_owned_after_display":"5,707,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-20","scope":"insider","n_lines":2},{"id":2101814,"accession":"0000899243-20-028811","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-028811","line_url":"/filing/0000899243-20-028811#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_display_name":"Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7697.0,"shares_display":"7,697","price_per_share":33.5728,"price_display":"33.57","price_state":"stated","total_value":258409.8416,"total_display":"258,409.84","total_whole":"258,410","shares_owned_after":5711275.0,"shares_owned_after_display":"5,711,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-16","filed_date":"2020-10-20","scope":"insider"}],"collapsed":true,"next_cursor":"2020-10-16|2101814","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001701541","name":"Black Diamond Therapeutics, Inc.","url":"/issuer/0001701541","role":"Ten percent owner","n_filings":16,"first_seen":"2020-02-05","last_seen":"2024-08-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"CHINOOK THERAPEUTICS, INC.","url":"/issuer/0001435049","role":"Ten percent owner","n_filings":2,"first_seen":"2021-08-31","last_seen":"2022-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001745960","retrieved_at":"2026-08-22T15:16:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}